CONTEXT: Adenocarcinoma already comprises half the cases of lung cancer. Its insidious clinical evolution contributes to the fact that, in absolute numbers, lung tumor is the cancer with the highest mortality in the w...CONTEXT: Adenocarcinoma already comprises half the cases of lung cancer. Its insidious clinical evolution contributes to the fact that, in absolute numbers, lung tumor is the cancer with the highest mortality in the world. When still in situ, the adenocarcinoma is even quieter, making its typical presentation on the computerized tomography of an irregular semisolid nodule smaller than 3.0 cm. It is often diagnosed in a finding of examination in an asymptomatic patient. The prevalence of in situ adenocarcinoma (ISA) is less than 5% of pulmonary malignancies and its radiological presentation with a diffuse mosaic paving pattern is even more unusual, mimicking other conditions more frequent to this finding. CASE REPORT: We describe the case of a 44-year-old male patient with a history of chronic smoking admitted to the emergency room at a referral hospital in S?o Paulo on 12/16/2016 with a complaint of progressive dyspnea associated with dry cough for 3 months, intermittent fever and weight loss of 8 kg in 2 months. A chest X-ray and computed tomography showed discrete focal points of peribroncovascular consolidation, predominantly central, areas with frosted glass attenuation associated with smooth thickening of the interlobular septa, sometimes interspersed with areas of preserved parenchyma, giving an aspect of “crazing paving” with diffuse distribution by the pulmonary parenchyma. The patient underwent a biopsy with the anatomicopathological diagnosis of primary Adenocarcinoma in situ of the lung. CONCLUSION: We emphasize that the “crazing paving” of adenocarcinoma in situ pulmonary should be considered and known by the radiologist, because although isolated it is a rare condition, its early distrust in cases of atypical evolution of the most common injuries can avoid a diagnosis in phases more advanced and higher mortality.展开更多
Objective： The relationship between anaplastic lymphoma kinase（ALK） expression in malignant pleural effusion（MPE） samples detected only by Ventana immunohistochemistry（IHC） ALK（D5F3） and the efficacy of ALKty...Objective： The relationship between anaplastic lymphoma kinase（ALK） expression in malignant pleural effusion（MPE） samples detected only by Ventana immunohistochemistry（IHC） ALK（D5F3） and the efficacy of ALKtyrosine kinase inhibitor therapy is uncertain.Methods： Ventana anti-ALK（D5F3） rabbit monoclonal primary antibody testing was performed on 313 cell blocks of MPE samples from Chinese patients with advanced lung adenocarcinoma, and fluorescence in situ hybridization（FISH） was used to verify the ALK gene status in Ventana IHC ALK（D5F3）-positive samples. The follow-up clinical data on patients who received crizotinib treatment were recorded.Results： Of the 313 MPE samples, 27（8.6%） were confirmed as ALK expression-positive, and the Ventana IHC ALK（D5F3）-positive rate was 17.3%（27/156） in wild-type epidermal growth factor receptor（EGFR） MPE samples. Twenty-three of the 27 IHC ALK（D5F3）-positive samples were positive by FISH. Of the 11 Ventana IHC ALK（D5F3）-positive patients who received crizotinib therapy, 2 patients had complete response（CR）, 5 had partial response（PR） and 3 had stable disease（SD）.Conclusions： The ALK gene expression status detected by the Ventana IHC ALK（D5F3） platform in MPE samples may predict tumor responsiveness to crizotinib in Chinese patients with advanced lung adenocarcinoma.展开更多
目的观察基于平扫CT瘤内及瘤周影像组学模型联合临床及常规CT特征鉴别肺原位腺癌(AIS)与微浸润性腺癌(MIA)的价值。方法回顾性分析180例孤立性AIS及180例孤立性MIA肺结节患者,随机将其中各160例纳入训练集(n=320)、各20例纳入测试集(n=...目的观察基于平扫CT瘤内及瘤周影像组学模型联合临床及常规CT特征鉴别肺原位腺癌(AIS)与微浸润性腺癌(MIA)的价值。方法回顾性分析180例孤立性AIS及180例孤立性MIA肺结节患者,随机将其中各160例纳入训练集(n=320)、各20例纳入测试集(n=40)。以训练集AIS与MIA间差异有统计学意义的临床及常规CT特征构建临床模型;勾画瘤内(CTi)及包含瘤周2 mm(CTi+p2mm)、4 mm(CTi+p4mm)ROI,提取并筛选其影像组学特征,分别以之构建CTi模型、CTi+p2mm模型及CTi+p4mm模型;绘制受试者工作特征(ROC)曲线,计算曲线下面积(AUC),评价各模型效能,遴选预测测试集MIA效能最佳者,联合临床及常规CT特征构建联合模型,观察临床模型、最佳影像组学模型及联合模型的AUC、校准度及净收益。结果训练集内,相比AIS,MIA结节直径较大、密度不均匀、伴血管穿行结节占比较高(P均<0.05)。CTi+p2mm模型鉴别测试集MIA与AIS效能最高(AUC=0.838,P<0.05);以之结合临床及常规CT特征构建的联合模型鉴别诊断效能更佳(AUC=0.867,P<0.05)。联合模型的校准度及0.60~0.90阈值概率区间的临床净收益较高。结论基于平扫CT构建的瘤内和瘤周2 mm ROI影像组学模型能有效鉴别肺MIA与AIS,联合临床及常规CT特征可进一步提高模型鉴别效能。展开更多
文摘CONTEXT: Adenocarcinoma already comprises half the cases of lung cancer. Its insidious clinical evolution contributes to the fact that, in absolute numbers, lung tumor is the cancer with the highest mortality in the world. When still in situ, the adenocarcinoma is even quieter, making its typical presentation on the computerized tomography of an irregular semisolid nodule smaller than 3.0 cm. It is often diagnosed in a finding of examination in an asymptomatic patient. The prevalence of in situ adenocarcinoma (ISA) is less than 5% of pulmonary malignancies and its radiological presentation with a diffuse mosaic paving pattern is even more unusual, mimicking other conditions more frequent to this finding. CASE REPORT: We describe the case of a 44-year-old male patient with a history of chronic smoking admitted to the emergency room at a referral hospital in S?o Paulo on 12/16/2016 with a complaint of progressive dyspnea associated with dry cough for 3 months, intermittent fever and weight loss of 8 kg in 2 months. A chest X-ray and computed tomography showed discrete focal points of peribroncovascular consolidation, predominantly central, areas with frosted glass attenuation associated with smooth thickening of the interlobular septa, sometimes interspersed with areas of preserved parenchyma, giving an aspect of “crazing paving” with diffuse distribution by the pulmonary parenchyma. The patient underwent a biopsy with the anatomicopathological diagnosis of primary Adenocarcinoma in situ of the lung. CONCLUSION: We emphasize that the “crazing paving” of adenocarcinoma in situ pulmonary should be considered and known by the radiologist, because although isolated it is a rare condition, its early distrust in cases of atypical evolution of the most common injuries can avoid a diagnosis in phases more advanced and higher mortality.
基金supported by grants from the Beijing Municipal Science and Technology Commission(D141100000214003)the Natural Science Foundation of China(No.81641114)
文摘Objective： The relationship between anaplastic lymphoma kinase（ALK） expression in malignant pleural effusion（MPE） samples detected only by Ventana immunohistochemistry（IHC） ALK（D5F3） and the efficacy of ALKtyrosine kinase inhibitor therapy is uncertain.Methods： Ventana anti-ALK（D5F3） rabbit monoclonal primary antibody testing was performed on 313 cell blocks of MPE samples from Chinese patients with advanced lung adenocarcinoma, and fluorescence in situ hybridization（FISH） was used to verify the ALK gene status in Ventana IHC ALK（D5F3）-positive samples. The follow-up clinical data on patients who received crizotinib treatment were recorded.Results： Of the 313 MPE samples, 27（8.6%） were confirmed as ALK expression-positive, and the Ventana IHC ALK（D5F3）-positive rate was 17.3%（27/156） in wild-type epidermal growth factor receptor（EGFR） MPE samples. Twenty-three of the 27 IHC ALK（D5F3）-positive samples were positive by FISH. Of the 11 Ventana IHC ALK（D5F3）-positive patients who received crizotinib therapy, 2 patients had complete response（CR）, 5 had partial response（PR） and 3 had stable disease（SD）.Conclusions： The ALK gene expression status detected by the Ventana IHC ALK（D5F3） platform in MPE samples may predict tumor responsiveness to crizotinib in Chinese patients with advanced lung adenocarcinoma.
文摘目的观察基于平扫CT瘤内及瘤周影像组学模型联合临床及常规CT特征鉴别肺原位腺癌(AIS)与微浸润性腺癌(MIA)的价值。方法回顾性分析180例孤立性AIS及180例孤立性MIA肺结节患者,随机将其中各160例纳入训练集(n=320)、各20例纳入测试集(n=40)。以训练集AIS与MIA间差异有统计学意义的临床及常规CT特征构建临床模型;勾画瘤内(CTi)及包含瘤周2 mm(CTi+p2mm)、4 mm(CTi+p4mm)ROI,提取并筛选其影像组学特征,分别以之构建CTi模型、CTi+p2mm模型及CTi+p4mm模型;绘制受试者工作特征(ROC)曲线,计算曲线下面积(AUC),评价各模型效能,遴选预测测试集MIA效能最佳者,联合临床及常规CT特征构建联合模型,观察临床模型、最佳影像组学模型及联合模型的AUC、校准度及净收益。结果训练集内,相比AIS,MIA结节直径较大、密度不均匀、伴血管穿行结节占比较高(P均<0.05)。CTi+p2mm模型鉴别测试集MIA与AIS效能最高(AUC=0.838,P<0.05);以之结合临床及常规CT特征构建的联合模型鉴别诊断效能更佳(AUC=0.867,P<0.05)。联合模型的校准度及0.60~0.90阈值概率区间的临床净收益较高。结论基于平扫CT构建的瘤内和瘤周2 mm ROI影像组学模型能有效鉴别肺MIA与AIS,联合临床及常规CT特征可进一步提高模型鉴别效能。
